Blue Biofuels (BIOF) 10-K/A 15 Apr 15 2014 FY Annual report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Dec. 31, 2014	Apr. 14, 2015	Jun. 30, 2014
Document and Entity Information [Abstract]
Entity Registrant Name	ALLIANCE BIOENERGY PLUS, INC.
Entity Central Index Key	1549145
Amendment Flag	FALSE
Current Fiscal Year End Date	-19
Document Type	10-K
Document Period End Date	31-Dec-14
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	FY
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		37,718,225
Entity Public Float			$13,162,746

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Dec. 31, 2014	Dec. 31, 2013
Current assets
Cash and cash equivalents	$205,969	$48,968
Prepaid expenses	470,612	1,533,842
Current assets of discontinued operations	11,263	22,147
TOTAL CURRENT ASSETS	687,844	1,604,957
PROPERTY AND EQUIPMENT, AT COST, NET OF ACCUMULATED DEPRECIATION OF $15,883 AND $906 AT DECEMBER 31, 2014 AND DECEMBER 31, 2013, RESPECTIVELY	140,387	9,159
Other assets
Security deposits	7,278	3,000
Investment in and advances to an unconsolidated affiliate	7,497,437	7,459,323
Long term assets of discontinued operations		975,744
TOTAL OTHER ASSETS	7,504,715	8,438,067
TOTAL ASSETS	8,332,946	10,052,183
Current liabilities
Accounts payable and accrued liabilities	182,295	42,969
Liability for stock to be issued		354,500
Payable relating to an acquisition - Related party	2,031,258	2,200,000
Short term note payable - Related party	71,000	71,000
Convertible debentures payable - Other		70,000
Interest payable - Related Party	5,486	1,937
Interest payable - Other	1,417	11,649
Current liabilities of discontinued operations	733,762	756,795
TOTAL CURRENT LIABILITIES	3,025,218	3,508,850
Long term liabilities
Long term notes payable - Other	1,250,000
TOTAL LONG TERM LIABILITIES	1,250,000
TOTAL LIABILITIES	4,275,218	3,508,850
STOCKHOLDERS' EQUITY
Preferred stock; $0.001 par value; 10,000,000 shares authorized; zero shares issued and outstanding
Common stock; $0.001 par value; 100,000,000 shares authorized; 40,340,738 shares issued and outstanding at December 31, 2014 and 32,840,476 shares issued and outstanding at December 31, 2013	40,341	32,841
Stock Subscription Receivable	-10,000	-10,000
Additional paid-in capital	16,374,470	8,930,015
Accumulated deficit	-12,208,326	-2,409,309
Total stockholders' equity	4,196,485	6,543,547
Non-controlling interest	-138,757	-214
TOTAL EQUITY	4,057,728	6,543,333
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$8,332,946	$10,052,183

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Paranthetical) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Balance Sheets [Abstract]
Net of accumulated depreciation and amortization on property and equipment	$15,883	$906
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	40,340,738	32,840,476
Common stock, shares outstanding	40,340,738	32,840,476

Consolidated_Statement_of_Oper

Consolidated Statement of Operations (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Statements Of Operations [Abstract]
Revenues
Operating expense
General and administrative	7,677,229	2,204,629
Total operating expenses	7,677,229	2,204,629
Loss from operations	-7,677,229	-2,204,629
Other expenses
Equity loss in an unconsolidated affiliate	208,113
Interest expense - related party	1,629	1,936
Interest expense - other	9,516	9,095
Total other expenses	-219,258	-11,031
Loss from continuing operations	-7,896,487	-2,215,660
Discontinued operations
Loss from operations	-978,490	-88,639
Loss on impairment	-924,040
Loss from discontinued operations	-1,902,530	-88,639
Loss before provisions for income taxes	-9,799,017	-2,304,299
Provisions for income taxes
Net loss	-9,799,017	-2,304,299
Net loss attributable to non-controlling interest	-138,543	-214
Net loss attributable to Company	($9,937,560)	($2,304,513)
Basic and diluted net loss per share
Continuing operations	($0.22)	($0.11)
Discontinued operations	($0.05)	$0
Net loss per share	($0.27)	($0.11)
Weighted average common shares outstanding
Basic and Diluted	37,029,419	20,270,384

Condensed_Statements_of_Stockh

Condensed Statements of Stockholders' Equity (USD $)		Total	Common Stock	Preferred Stock	Stock Subscription Receivable	Additional Paid -in Capital	Accumulated Deficit	Non-controlling Interest
		USD ($)	USD ($)		USD ($)	USD ($)	USD ($)	USD ($)
Beginning Balance at Dec. 31, 2012		($55,165)	$19,395		($19,000)	$49,450	($105,010)
Beginning Balance, Shares at Dec. 31, 2012			19,395,000
Issuance of common stock for services		860,198	2,301			858,897
Issuance of common stock for services, Shares			2,300,477
Issuance of common stock for prepaid expenses, value		1,500,000	2,000			1,498,000
Issuance of common stock for prepaid expenses, Shares			2,000,000
Issuance of warrants for services		902,772				902,772
Issuance of common stock in connection with conversion of notes payable		10,000	83			9,917
Issuance of common stock in connection with conversion of notes payable, Shares			83,333
Issuance of common stock for cash		156,001	195		9,000	145,806
Issuance of common stock for cash, Shares			194,666
Issuance of common stock for acquisition	[1]	224,040	1,867			222,173
Issuance of common stock for acquisition, Shares	[1]		1,867,000
Issuance of common stock for acquisition (2)	[2]	5,250,000	7,000			5,243,000
Issuance of common stock for acquisition (2), Shares	[2]		7,000,000
Net loss		-2,304,513
Ending Balance at Dec. 31, 2013		6,543,333	32,841		-10,000	8,930,015	-2,409,309	-214
Ending Balance, Shares at Dec. 31, 2013			32,840,476
Issuance of common stock for services		6,027,587	5,690			6,021,897
Issuance of common stock for services, Shares			5,689,503
Cancellation of common stock for prepaid expenses		-1,500,000	-2,000			-1,498,000
Cancellation of common stock for prepaid expenses, Shares			-2,000,000
Issuance of warrants for services		278,850				278,850
Issuance of common stock in connection with conversion of notes payable		57,862	458			57,404
Issuance of common stock in connection with conversion of notes payable, Shares			458,333
Issuance of common stock for cash		2,402,180	3,203			2,398,977
Issuance of common stock for cash, Shares			3,203,295
Cancellation of common stock from acquisition	[1]	-14,024	-117			-13,907
Cancellation of common stock from acquisition, Shares	[1]		-116,869
Issuance of common stock for acquisition (2)	[2]	199,500	266			199,234
Issuance of common stock for acquisition (2), Shares	[2]		266,000
Net loss		-9,937,560
Ending Balance at Dec. 31, 2014		$4,057,728	$40,341		($10,000)	$16,374,470	($12,208,326)	($138,757)
Ending Balance, Shares at Dec. 31, 2014			40,340,738
[1]	(1) Stock issued for rights to two partially-completed television series "World Star" and "Making of a Saint: The Journey to Sainthood"
[2]	(2) Stock issued for acquisition of AMG Energy Group, LLC

Condensed_Statements_of_Stockh1

Condensed Statements of Stockholders' Equity (Parenthetical)	Dec. 31, 2014	Dec. 31, 2013
Statement of Stockholders' Equity [Abstract]
Number of warrants for services	500,000	2,000,000

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities
Net loss from continuing operations	($7,896,487)	($2,215,660)
Net loss from discontinued operations	-1,902,530	-88,639
Net Loss from non-controlling interest	-138,543	-214
Net loss	-9,937,560	-2,304,513
Reconciliation of net loss to net cash used in operating activities
Depreciation and amortization	13,042	906
Accrued interest on convertible debentures		10,885
Stock based compensation	6,027,587	861,198
Issuance of warrants for services	23,237	902,772
Equity loss in an unconsolidated affiliate	208,113
Changes in operating assets and liabilities
Prepaid expenses	-181,158	-3,842
Accounts payable and accrued liabilities	-14,494	120,418
Net cash used in operating activities - continuing operations	-1,958,703	-412,176
Net cash used in operating activities - discontinued operations	-917,565	-105,380
Net cash used in operating activities	-2,876,268	-517,556
Cash flows from investing activities
Purchase of property and equipment	-138,864	-10,065
Security deposit	-4,278	-3,000
Investment in and advance to an unconsolidated affiliate	-246,227	214,894
Net cash from (used in) investing activities - continuing operations	-389,369	201,829
Net cash from (used in) investing activities - discontinued operations		-57,110
Net cash from (used in) investing activities	-389,369	144,719
Cash flows from financing activities
Debt payment relating to an acquisition	-168,742
Proceeds from short-term note payable - related party		71,000
Proceeds from long-term note payable - other	1,250,000
Net proceeds from issuance of common stock	2,402,180	155,001
Net proceeds of common stock to be issued		155,000
Repayment of convertible debt	-20,000
Net cash provided by financing activities - continuing operations	3,463,438	381,001
Net cash provided by financing activities - discontinued operations	-40,800	40,800
Net cash provided by financing activities	3,422,638	421,801
Net increase in cash and cash equivalents	157,001	48,964
Cash and cash equivalent at beginning of the period	48,968	4
Cash and cash equivalent at end of the period	205,969	48,968
Cash paid during the period for
Interest	11,145
Taxes	480
Supplemental schedule of non-cash activities
Conversion of convertible debenture to common stock	50,000	10,000
Conversion of Interest to Common Stock	7,863
Common stock issued for investment in carbolosic	199,500	5,250,000
Common stock to be issued for investment in Carbolosic		199,500
Common stock (returned) issued recorded for prepaid expense	-1,500,000	1,500,000
Reversal of common stock issued for investment in discontinued operations	-14,024	224,040
Debt incurred for acquisition of Carbolosic		2,200,000
Debt incurred for acquisition in discontinued operations		700,000
Issuance of warrants for future services	$255,612

Organization

Organization	12 Months Ended
	Dec. 31, 2014
Organization [Abstract]
ORGANIZATION	NOTE 1 – ORGANIZATION
	Alliance Bioenergy Plus, Inc (the “Company”) is a technology company focused on emerging technologies in the renewable energy, biofuels and new technologies sectors. From inception through December 5, 2014, the Company was known as Alliance Media Group Holdings, Inc. At inception (March 28, 2012), the Company was organized as a vehicle to engage in the commercial production, distribution and exploitation of Motion Pictures and other Entertainment products. However, in December 2013, a wholly owned subsidiary of the Company, AMG Renewables, LLC (“AMG Renewables”), acquired the controlling interest (51%) in AMG Energy Group, LLC (“AMG Energy”), which owns a fifty percent (50%) interest of Carbolosic, LLC (“Carbolosic”), which holds an exclusive worldwide license to the University of Central Florida’s patented technology (U.S. Patent 8,062,428) known as “CTS™”. The CTS technology is a mechanical/chemical, dry process for converting cellulose material into sugar for use in the biofuels industry as well as other fine chemical manufacturing. The Company’s goal in acquiring the interest in AMG Energy is to develop the CTS technology to a commercial scale and then seek to license the technology to prospective licensees. In September 2014, the Company determined to focus all of the Company’s resources and personnel on the Company’s renewable energy holdings and future energy technologies and to divest the Company of its entertainment-related assets and subsidiaries. The principal reason for such action was the recognition that the Company’s entertainment-related assets were generating substantial losses and contributing little value compared to the potential management saw in the energy-related activities and to provide a clear focus and direction to the Company moving forward. The Company therefore determined at that time to divest and sell off, close down or discontinue the operations of its entertainment-related subsidiaries. Subsequently, the Company determined that the name Alliance Media Group Holdings, Inc. was no longer relevant to the new business direction of the Company and, effective December 5, 2014, amended the Company’s Articles of Incorporation to change the name of the Company to Alliance Bioenergy Plus, Inc., which is more appropriately descriptive of the new business direction of the Company.
	Plan of Operation
	The Company is focused on one industry – Renewable Energy. Through its wholly-owned subsidiaries, AMG Renewables, LLC and Carbolosic Plant 1, LLC, which in turn owns controlling interests in AMG Energy Group, LLC, and Central Florida Institute of Science and Technology, Inc., the Company has a strategy that includes growth in its energy-related activities as well as mergers and acquisitions and start-up activities which are focused on development of an increasing revenue stream, secure market share and enhancement of shareholder value.
	AMG RENEWABLES, LLC
	AMG Renewables, LLC, a Florida limited liability company (“AMG Renewables”), is a wholly-owned subsidiary of the Company, created for the purpose of managing and developing the Company’s renewable energy technology enterprises. AMG Renewables has one wholly-owned subsidiary, Carbolosic Plant 1, LLC, a Florida limited liability company (“Carbolosic Plant 1”), and two majority owned subsidiaries, AMG Energy Group, LLC, a Florida limited liability company (“AMG Energy”) and Central Florida Institute of Science and Technology, Inc., a Florida corporation (“CFIST”).
	●	On December 26, 2013, AMG Renewables acquired the controlling interest (51%) in AMG Energy Group from certain related parties for a consideration comprising $2,200,000 cash, payable upon the successful completion of the Company’s pending private offering, together with delivery of 7,266,000 shares of Company Common Stock. In connection with the transaction, an amount which the Company owed to AMG Energy ($214,894) for various loans and consulting fees was eliminated in the acquisition. On December 26, 2013, 7,000,000 shares of Company common stock were delivered to AMG Energy Solutions, Inc. (a related party) and the remaining 266,000 shares of Company common stock were delivered on June 18, 2014 to Wellington Asset Holdings, Inc. As of December 31, 2014, the Company has paid $168,742 of the $2,200,000 cash payable on account of this transaction, and as of such date, the proceeds of the Company’s pending private offering have been insufficient to pay the remaining amount, which amount has been recorded on the books of the Company as a related party payable relating to an acquisition.
	●	AMG Energy owns a fifty percent (50%) interest of Carbolosic, LLC, a Delaware limited liability company (“Carbolosic”), which holds an exclusive worldwide license to the University of Central Florida’s patented technology (U.S. Patent 8,062,428) known as “CTS™”. The CTS technology is a mechanical/chemical, dry process for converting cellulose material into sugar for use in the biofuels industry as well as other fine chemical manufacturing. The Company’s goal is to develop this CTS technology to a commercial scale and then seek to license the technology to prospective licensees.
	●	Carbolosic Plant 1 was created in October 2014 for the purpose of being a full scale facility for converting cellulose material into sugar for use in the biofuels industry as well as other fine chemical manufacturing located in Palm Beach County, FL.
	●	CFIST, was created in December 2014 as a wholly owned subsidiary of AMG Energy, to serve as a demonstration and research facility to further develop the CTS process, its uses, and develop new technologies.
	The Company believes that its management and consultants have significant experience in the bio-fuels, renewable energy and chemical manufacturing industries. As of this date, the Company has not generated any revenues from its renewable energy business.

Going_Concern

Going Concern	12 Months Ended
	Dec. 31, 2014
Going Concern [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN
	The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern, which assumes the Company will realize its assets and discharge its liabilities in the normal course of business. The Company has not generated any revenue, has incurred losses since inception, has a working capital deficiency of $2,337,374 and may be unable to raise further equity. At December 31, 2014 the Company had incurred accumulated losses of $12,208,326 since its inception. The Company expects to incur significant additional liabilities in connection with its start-up activities. The Company’s ability to continue as a going concern is dependent upon its ability to obtain the necessary financing to meet its obligations and repay its liabilities when they become due and to generate sufficient revenues from its operations to pay its operating expenses. These Financial Statements do not include any adjustments related to the recoverability and classifications of recorded asset amounts, or amounts and classifications of liabilities that might result from this uncertainty. There are no assurances that the Company will continue as a going concern.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2014
Summary of Significant Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
	Basis of Presentation
	The accompanying consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of the Company’s majority-owned subsidiaries over which the Company exercises control. Intercompany transactions and balances were eliminated in consolidation.
	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries, after elimination of intercompany accounts and transactions. Investments in business entities in which the Company lacks control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. The Company’s proportionate share of net income or loss of the entity is recorded in the Consolidated Statements of Operations.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates presented and reported amounts of revenues and expenses during the reporting periods presented. Significant estimates inherent in the preparation of the accompanying Consolidated Financial Statements include estimates of impairment assessment of identifiable intangible assets and valuation allowance for deferred tax assets. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ from these estimates.
	Cash and Cash Equivalents
	All highly liquid investments with maturities of three months or less at the date of purchase are considered to be cash equivalents.
	Stock Compensation
	The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation” (formerly referred to as SFAS No. 123(R)). Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, ASC Topic 505, “Equity Payments to Non-Employees” or other applicable authoritative guidance.
	Accounting and Reporting of Discontinued Operations
	As required by the FASB ASC Subtopic 205.20, per ASU 2014-08, Discontinued Operations, a component of an entity or a group of components of an entity, or a business or nonprofit activity can be classified as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when any of the following occurs: (i) the criteria in paragraph 205.20.45.1E to be classified as held for sale is met (ii) the component is disposed of by sale, or (iii) the component is disposed of other than by sale in accordance with paragraph 360.10.45.15 (for example, by abandonment or in a distribution to owners in a spinoff). Certain components to be disposed of other than by sale shall continue to be classified as “held and used” until it is disposed of, per the requirements of ASC Subtopic 360.10. Depreciation on these assets ceases upon their classification as “held and used.” The Company adopted ASU No. 2014-08 effective September 1, 2014.
	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets, generally 5 to 7 years. Expenditures for additions and improvements are capitalized; repairs and maintenance are expensed as incurred.
	Convertible Instruments
	The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.
	Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.
	The Company accounts for convertible instruments (when we have determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.
	Common Stock Purchase Warrants and Other Derivative Financial Instruments
	The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
	Non-controlling interest in consolidated subsidiaries
	The accompanying consolidated financial statements include the accounts of Alliance BioEnergy Plus, Inc. and those subsidiaries that the Company has the ability to control either through voting rights or means other than voting rights. For these subsidiaries, the Company records 100% of the revenues, expenses, cash flows, assets and liabilities in its consolidated financial statements. For subsidiaries that the Company controls but hold less than 100% ownership, a non-controlling interest is recorded in the consolidated income statement to reflect the non-controlling interest’s share of the net income (loss), and a non-controlling interest is recorded in the consolidated balance sheet to reflect the non-controlling interest’s share of the net assets of the subsidiary.
	Investments in non-consolidated affiliates
	Investments in non-consolidated affiliates are accounted for using the equity method or cost basis depending upon the level of ownership and/or the Company's ability to exercise significant influence over the operating and financial policies of the investee. When the equity method is used, investments are recorded at original cost and adjusted periodically to recognize the Company's proportionate share of the investees' net income or losses after the date of investment. When net losses from an investment are accounted for under the equity method exceed its carrying amount, the investment balance is reduced to zero and additional losses are not provided for. The Company resumes accounting for the investment under the equity method if the entity subsequently reports net income and the Company's share of that net income exceeds the share of net losses not recognized during the period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value that is other than temporary has occurred.
	The Company’s investment in Carbolosic, LLC is accounted for using the equity method of accounting. The Company monitors its investment for impairment at least annually and make appropriate reductions in the carrying value if it determines that an impairment charge is required based on qualitative and quantitative information.
	Impairment of Long Lived Assets
	Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable, the Company compares the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell.
	Income Taxes
	The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized.
	ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions for any of the reporting periods presented.
	Profit (Loss) per Common Share:
	Basic profit (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. The warrants and options are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive.
	Fair Value Measurements
	The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.
	The estimated fair value of certain financial instruments, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.
	ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:
	Level 1 — quoted prices in active markets for identical assets or liabilities
	Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable
	Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
	Recent Accounting Pronouncements
	From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.
	In June 2014, the FASB issued ASU No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation. The amendments in this Update remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer in a development stage that in prior years it had been in the development stage. The Company has elected early adoption of ASU No. 2014-10 and does not present inception to date information and other disclosure requirements of Topic 915.
	The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations. Finally, the amendments remove paragraph 810-10-15-16. Paragraph 810-10-15-16 states that a development stage entity does not meet the condition in paragraph 810-10-15-14(a) to be a variable interest entity if (1) the entity can demonstrate that the equity invested in the legal entity is sufficient to permit it to finance the activities that it is currently engaged in and (2) the entity’s governing documents and contractual arrangements allow additional equity investments. The amendments in this Update also eliminate an exception provided to development stage entities in Topic 810, Consolidation, for determining whether an entity is a variable interest entity on the basis of the amount of investment equity that is at risk. The amendments to eliminate that exception simplify GAAP by reducing avoidable complexity in existing accounting literature and improve the relevance of information provided to financial statement users by requiring the application of the same consolidation guidance by all reporting entities. The elimination of the exception may change the consolidation analysis, consolidation decision, and disclosure requirements for a reporting entity that has an interest in an entity in the development stage. The amendments related to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 should be applied retrospectively except for the clarification to Topic 275, which shall be applied prospectively. For public business entities, those amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued (public business entities) or made available for issuance (other entities). The company has elected early adoption of Topic 275 for the year ended December 2014.

Investment_in_Unconsolidated_A

Investment in Unconsolidated Affiliate	12 Months Ended
	Dec. 31, 2014
Investment in Unconsolidated Affiliate [Abstract]
INVESTMENT IN UNCONSOLIDATED AFFILIATE	NOTE 4 – INVESTMENT IN UNCONSOLIDATED AFFILIATE
	On December 26, 2013, AMG Renewables, LLC, a Florida limited liability company (“AMG Renewables”), a wholly-owned subsidiary of the Company, acquired the controlling interest (51%) in AMG Energy Group, LLC a Florida limited liability company (“AMG Energy”) from certain related parties. AMG Energy owns a fifty percent (50%) interest of Carbolosic, LLC, a Delaware limited liability company (“Carbolosic”), which holds an exclusive worldwide license to the University of Central Florida’s patented technology (U.S. Patent 8,062,428) known as “CTS™”. The CTS technology is a mechanical/chemical, dry process for converting cellulose material into sugar for use in the biofuels industry as well as other fine chemical manufacturing. The results of AMG Renewables and AMG Energy are consolidated in the Company’s financial statements. AMG Energy’s investment in Carbolosic is accounted for using the equity method of accounting.
	Condensed Balance Sheet of Non-Consolidated Affiliate
		31-Dec-14			31-Dec-13
	ASSETS
	Current Assets
	Cash and cash equivalents	$	1,000		$	-
	TOTAL ASSETS	$	1,000		$	-
	LIABILITIES AND STOCKHOLDERS EQUITY
	Current Liabilities
	Accounts payable and accrued liabilities	$	35,000		$	-
	Interest payable		1,218			-
	Current notes payable		381,008			-
	TOTAL CURRENT LIABILITIES		417,226			-
	STOCKHOLDERS EQUITY
	Accumulated deficit		(416,226	)		-
	TOTAL EQUITY		(416,226	)		-
	TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	$	1,000		$	-
	Condensed Statement of Operations of Non-Consolidated Affiliate
		For The Year Ended			For The Year Ended
		31-Dec-14			31-Dec-13
	Revenues	$	-		$	-
	Operating Expenses
	Royalties		35,000			-
	Legal fees		377,330			-
	General and administrative		2,678			-
	Total operating expenses		(415,008	)		-
	Other expenses
	Interest expense		1,218			-
	Total other expenses		(1,218	)		-
	Loss from operations	$	(416,226	)	$	-

Debt

Debt	12 Months Ended
	Dec. 31, 2014
Debt [Abstract]
DEBT	NOTE 5 – DEBT
	Short Term Notes Payable—Related Parties
	Throughout 2013, the Company issued five unsecured short-term notes payable to various related parties, including officers and directors of the Company, with a term of one year. During the fiscal year ended December 31, 2014, three of these notes were repaid and two notes were extended and remain outstanding. The outstanding notes have a combined principal balance of $71,000, accrued interest of $5,486 and bear interest at a rate of five percent (5%) per annum.
	Short Term Notes Payable – Other
	During September 2014, the Company entered into a one year promissory note with United States Regional Economic Development Authority, LLC (USREDA) for $500,000 bearing interest at 4% per annum. The full principal and interest due on this note was repaid on October 17, 2014.
	Long Term Notes Payable – Other
	During the year ended December 31, 2014, Carbolosic Plant 1, LLC, a wholly owned subsidiary, entered into an agreement with Carbolosic Energy 1, LLLP to begin receiving long term loans, pursuant to the U.S. EB-5 Immigrant Investor Program, to develop a CTS demonstration facility. These loans will be issued in multiple advances, each in an amount greater than or equal to $500,000 up to the target loan amount of $33,000,000. The initial term on each of these loans is five (5) years from the date of each advance and bear interest at a rate of 4.31% per annum. The Company can earn a 0.51% rate discount if the first five years of interest due to lender is paid within 15 days of each advance. In addition, these loans may not be prepaid and are secured by all assets of the Company. As of December 31, 2014, the Company had received two (2) long term notes payable, with a combined principal balance of $1,250,000. The company has taken advantage of the 0.51% rate discount on one of these notes payable, with a principal amount of $500,000, and issued a $95,000 interest payment to the Lender on December 9, 2014.
	Convertible Debt
	On July 6, 2012, the Company entered into a Convertible Debenture with a related party with a face amount of $50,000 due and payable on or before July 1, 2013. Thereafter, on July 31, 2012, the Company entered into a Convertible Debenture with another related party of the Company, with a face amount of $30,000 due and payable on or before July 31, 2013. Each of the Convertible Debentures accrued interest at a rate of ten percent (10%) per annum and was convertible into the Company’s Common Stock in whole or in part at the option of the holder at a conversion rate of $0.12 per share. The Convertible Debentures would automatically convert into Company Common Stock at the conversion rate in the event shares of Company Common Stock traded at a price of $1.00 or more for thirty (30) consecutive trading days; in the event of a Qualified Sale (as defined in the Convertible Debenture); in the event of a merger where shareholders prior to the merger hold less than 50% of the voting power with respect to Company Common Stock following the merger; or upon the completion by the Company of an underwritten initial public offering of the Company’s Common Stock with gross proceeds of at least $5,000,000. $10,000 of the face amount of one of the Convertible Debentures was converted to 83,333 shares of Common Stock in September 2013 and the remaining $20,000 principal and accrued interest was paid on April 7, 2014. $50,000 of the principal and accrued interest thereon of the aggregate amount of the outstanding convertible debentures was converted to 458,333 shares of Common Stock on January 31, 2014. The company assesses the value of the beneficial conversion feature of its convertible debt by determining the intrinsic value of such conversion, under ASC 470, at the time of issuance. At the time of issuance of the convertible debt instrument set out above, the fair value of the stock was either the same or less than the conversion price, and so there was no value attributable to any beneficial conversion feature.

Stockholders_Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2014
Stockholders' Equity [Abstract]
STOCKHOLDERS' EQUITY	NOTE 6 – STOCKHOLDERS’ EQUITY
	The total number of shares of capital stock, which the Company has authority to issue, is one hundred ten million (110,000,000), one hundred million (100,000,000) of which are designated as common stock at $0.001 par value (the “Common Stock”) and ten million (10,000,000) of which are designated as preferred stock par value $0.001 (the “Preferred Stock”). As of December 31, 2014, the Company had 40,340,738 shares of Common Stock issued and outstanding and no shares of Preferred Stock were issued. Holders of shares of Common stock shall be entitled to cast one vote for each share held at all stockholders’ meetings for all purposes, including the election of directors. The Common Stock does not have cumulative voting rights. No holder of shares of stock of any class shall be entitled as a matter of right to subscribe for or purchase or receive any part of any new or additional issue of shares of stock of any class, or of securities convertible into shares of stock of any class, whether now hereafter authorized or whether issued for money, for consideration other than money, or by way of dividend. The Company has yet to designate any rights, preferences and privileges for any of its authorized Preferred Stock.
	In November 2013, the Company commenced an offering of up to 12,000,000 shares of Common Stock at a price of $0.75 per Share (the “Offering”). In the years ended December 31, 2014 and December 31, 2013, the Company had sold 3,203,295 and 194,666 shares of Common Stock through the Offering for aggregate proceeds of $2,402,180 and 156,001 respectively, of which 10,000 is a stock subscription receivable. The Offering was terminated in March 2015.
	During the fiscal year ended December 31, 2013, the Company issued an aggregate of 4,300,477 shares of its common stock for services valued at $2,361,198. (i) The value of 2,000,000 of these shares ($1,500,000) was recorded as a prepaid expense in 2013 as the related consulting agreement was terminated and the shares have been tendered to the Company for cancellation. The Company recorded $1,500,000 as an offset to this prepaid expense on account of the share cancellation in the quarter ended March 31, 2014. (ii) The Company also entered into a one year agreement with Constellation Asset Advisors, Inc to receive investor relations services commencing January 2014. In connection with this agreement, the Company issued to Constellation Asset Advisors, Inc. 967,810 shares of Company Common Stock, which are being amortized over the life of the agreement.
	During the fiscal year ended December 31, 2014, the Company entered into a Common Stock Purchase Warrant agreement with EraStar, Inc. whereby it issued a Warrant to purchase 500,000 shares of Common Stock for a period of five (5) years at an exercise price of $1.00 per share. Using a Black-Scholes asset pricing model, this agreement was valued at $278,850 and is being amortized over the life of the agreement.
	During the fiscal year ended December 31, 2014, the Company issued an aggregate of 458,333 shares of its common stock on account of the conversion of certain Debentures with a principal and interest amount of $57,862.
	During the fiscal year ended December 31, 2014, the Company canceled an aggregate of 116,869 shares of its common stock, valued at $14,024, as part of a legal settlement relating to a certain acquisition.
	During the fiscal year ended December 31, 2014, the Company issued an aggregate of 266,000 shares of its common stock as partial consideration for certain acquisitions valued at $199,500.
	During the fiscal year ended December 31, 2014, the Company granted an aggregate of 5,689,503 shares of its common stock for services valued at $6,027,587. 3,000,000 shares to a consultant for services valued at $3,450,000 were granted, but had not been issued as of December 31, 2014. These shares have been expensed and are included in paid in capital.
	During the fiscal year ended December 31, 2014, the company issued 1,000,000 shares for aggregate proceeds of $750,000 along with two Common Stock Purchase Warrant agreements to a certain party who owns 50% of an unconsolidated affiliate. The company later refunded the $750,000 upon receiving documentation from the party’s legal counsel that the warrant agreements and shares have been cancelled.

Segment_Information

Segment Information	12 Months Ended
	Dec. 31, 2014
Segment Information [Abstract]
SEGMENT INFORMATION	NOTE 7 – SEGMENT INFORMATION
		December 31,
		2014		2013
	Revenue:
	Alliance BioEnergy Plus, Inc.	$	-	$	-
	Carbolosic Plant 1, LLC		-		-
	AMG Energy Group, LLC		-		-
	Central Florida Institute of Science and Technology, Inc.		-		-
	Total Revenue		-		-
	Net Operating Losses
	Alliance BioEnergy Plus, Inc.	$	7,725,009		2,215,439
	Carbolosic Plant 1, LLC		27,281		-
	AMG Energy Group, LLC		144,152		221
	Central Florida Institute of Science and Technology, Inc.		45		-
	Total Net Losses		7,896,487		2,215,660
	Total Assets:
	Alliance BioEnergy Plus, Inc.	$	447,634		1,593,364
	Carbolosic Plant 1, LLC		279,044		-
	AMG Energy Group, LLC		7,509,002		7,460,926
	Central Florida Institute of Science and Technology, Inc.		86,003		-
	Total Net Assets		8,321,683		9,054,292

Income_Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
INCOME TAXES	NOTE 8 – INCOME TAXES
	The reconciliation of income tax benefit at the U.S. statutory rate of 34% for the years ended December 31, 2014 and 2013 to the Company’s effective tax rate is as follows:
		Years Ended
		31-Dec-14		31-Dec-13
	Statutory federal income tax rate	-34%		-34%
	State income tax, net of federal benefits	-6%		-6%
	Valuation Allowance	40%		40%
	Income tax provision (benefit)	0%		0%
	The benefit for income tax is summarized as follows:
		Years Ended
		31-Dec-14			31-Dec-13
	Federal
	Current	$	-		$	-
	Deferred		(3,331,666	)		(783,462	)
	State
	Current		-			-
	Deferred		(587,941	)		(138,258	)
	Change in valuation allowance		3,919,607			921,720
	Income tax provision (benefit)	$	-		$	-
	The tax effects of temporary differences that give rise to the Company’s net deferred tax liability as of December 31, 2014 and 2013 are as follows:
		Years Ended
		31-Dec-14			31-Dec-13
	Deferred tax asset
	Net operating loss carryovers	$	4,883,331		$	963,724
	Total deferred tax assets		4,883,331			963,724
	Valuation Allowance		(4,883,331	)		(963,724	)
	Deferred tax asset, net of allowance	$	-		$	-
	As of December 31, 2014 and 2013, the Company had $12,208,326 and $2,409,309 of Federal net operating loss carryovers (“NOLs”) which begin to expire in 2033. Utilization of the NOLs may be subject to limitation under the Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under regulations.
	In assessing the realization of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Based on the assessment, management has established a full valuation allowance against the entire deferred tax asset relating to NOLs for every period because it is more likely than not that all of the deferred tax asset will not be realized.
	The Company files U.S. Federal and Florida tax returns that are subject to audit by tax authorities beginning with the year ended December 31, 2012. The Company’s policy is to classify assessments, if any, for tax and related interest and penalties as tax expense.

Commitments_and_Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 9 - COMMITMENTS AND CONTINGENCIES
	Litigation
	The Company is subject, from time to time, to litigation, claims and suits arising in the ordinary course of business.
	Leases
	The Company has leased office space pursuant to a lease for a period of forty (40) months from April 6, 2012 through August 5, 2015. The Lease Commencement Date was August 6, 2012. Annual rent commenced at approximately $46,250 per annum and increases on a year-to-year basis by three percent (3%) over the Base Year. In addition, the Company is obligated to pay an amount equal to 3.76% of the operating expenses of the building together with sales tax on all amounts.
	The Company leased an additional office location during the year ended December 31, 2014. The lease period is for fifty-four (54) months from May 1, 2014 through October 31, 2018. The rent commencement date is November 1, 2014. Annual rent commences at approximately $51,338 per annum and increases on a year-to-year basis by three percent (3%) over the Base Year.
	Rent expense for the year ended December 31, 2014 and December 31, 2013 was $90,396 and $32,639 respectively.
	As of December 31, 2014, the total future minimum lease payments in respect of leased premises are as follows:
	YEAR ENDED	MINIMUM DUE
	2015	$	128,744
	2016		122,961
	2017		128,030
	2018		53,654
	2019		-
	TOTAL	$	433,389

Related_Party_Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2014
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 10 – RELATED PARTY TRANSACTIONS
	Related Transactions
	1) On January 2, 2013, the Company entered into three Consulting Agreements with related parties, (each calling for monthly payments to the consultant in the amount of $10,000). Under the terms of the Consulting Agreements, each Consultant would review and provide input on a variety of areas including corporate structure, marketing materials, website and promotional pieces; provide introductions to various organizations and individuals who might support the Company’s business development efforts and provide input and advice on the structuring of a private placement offering and the production of supporting materials. The Consulting Agreements would stay in place so long as the Company requires the Consultant’s services. All three agreements were terminated during the year ended December 31, 2104.
	2) Mark W. Koch and Daniel de Liege are principals of AMG Energy Solutions, Inc, which owns 43% of AMG Energy Group, LLC. The company owns 51% of AMG Energy Group, LLC (see NOTE 4, above).
	The officers and directors for the Company are involved in other business activities and may, in the future, become involved in other business opportunities. If a specific business opportunity becomes available, such persons may face a conflict in selecting between the Company and their other business interest. The Company has not formulated a policy for the resolution of such conflicts.
	3) Short-term notes payable issued to related parties are described in NOTE 5.
	4) On June 5, 2014 the company issued a $25,000 payment to Blake Koch Motorsports, Inc., for a marketing and advertising expense that occurred in March 2015. Blake Koch is the son of Mark W. Koch.
	5) On June 11, 2014 the Board of Directors approved the issuance of 3,000,000 shares of Company common stock valued at $3,450,000 to Joseph McNaney for services provided to AMG Renewables, LLC. The shares have not yet been issued as of December 31, 2014, but have been expensed and included in paid in capital.
	6) In October 2014, the Company issued 1,000,000 shares of common stock and two Common Stock Warrant Purchase agreements for 500,000 warrants each in exchange for $750,000 to Thor Renewable Energy (Singapore) ltd (“Thor”). On December 15, 2014, $750,000 was refunded to Thor upon the receipt of a legal document confirming the 1,000,000 shares and both warrant agreements were cancelled. Thor owns the remaining 50% of Carbolosic, LLC.

Discontinued_Operations

Discontinued Operations	12 Months Ended
	Dec. 31, 2014
Discontinued Operations [Abstract]
DISCONTINUED OPERATIONS	NOTE 11 – DISCONTINUED OPERATIONS
	On September 1, 2014, the Company determined the need to focus its resources and personnel on the Company’s renewable energy holdings and future energy technologies and to divest the company of its entertainment-related assets and subsidiaries. The principal reasons for such action is the expense, liability and losses that have been generated by the entertainment-related assets and to provide a clear focus and direction to the Company moving forward. Specifically, the Board approved the divesting, selling off, closing down or discontinuing of the operations of its entertainment-related subsidiaries, including but not limited to Prelude Pictures Entertainment, LLC, AMG Live, LLC, AMG Restaurant Operations, LLC (including The New York Sandwich Co.), AMG Music, LLC, AMG Releasing, LLC and AMG Television, LLC.
	Below is a reconciliation of the total assets and liabilities of the discontinued operations, which are presented separately on the balance sheet.
		December 31,			December 31,
		2014			2013
	Carrying amounts of major classes of assets included as part of discontinued
	operations
	Cash and cash equivalents	$	-		$	11,441
	Prepaid expenses		11,263			5,300
	Property and equipment, at cost, net of accumulated depreciation at December 31,		-			42,110
	2014 and December 31, 2013, respectively
	Security deposits		-			15,000
	Investment in film and television productions		-			924,040
	Total assets of the discontinued operation	$	11,263		$	997,891
	Carrying amounts of major classes of liabilities included as part of discontinued
	operations
	Accounts payable and accrued liabilities	$	733,762		$	715,000
	Short term note payable – Related party		-			40,800
	Interest payable – Related party		-			995
	Total liabilities of the discontinued operation	$	733,762		$	756,795
	Below is a reconciliation of the net loss of the discontinued operations, which are presented separately on the statement of operations.
		December 31,
		2014				2013
	Major line items constituting pretax profit (loss) of discontinued operations
	Revenue	$	36,540			$	-
	Cost of Sales		(23,189	)			-
	Selling, general and administrative		(991,103	)			(87,636	)
	Interest expense		(738	)			(995	)
	Loss on impairment		(924,040	)			-
	Loss from discontinued operations	$	(1,902,530	)		$	(88,639	)

Subsequent_Events

Subsequent Events	12 Months Ended
	Dec. 31, 2014
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 12 – SUBSEQUENT EVENTS
	The Company has evaluated subsequent events through the date the financial statements were available to be issued. Based on this evaluation, the Company has identified the following subsequent events:
	Equity
	In February 2015, the Company reached a legal settlement, whereby a net of 460,215 shares issued in connection with an acquisition had been returned to the company along with 500,000 shares of Company stock which had been previously issued in connection with payment for purported management services to be provided by certain of the defendants.
	During February 2015, Joseph McNaney returned a share certificate to the company representing 1,000,000 shares for rescission and forfeited his right to 3,000,000 unissued shares.
	During February 2015, the Company closed its initial offering of up to 12,000,000 shares of Common Stock at a price of $0.75 per share. Subsequently, the Company opened a 2nd offering of units valued at eight-five (85%) percent of the average of the last three days closing market share price. Each unit consists of one (1) share of Common Stock, one (1) three-year Series A Warrant convertible to .5 Common Share at an exercise price of $0.75 and one (1) three-year series B Warrant convertible to .5 Common Share at an exercise price of $1.50. Currently the Company has sold 1,687,702 units for aggregate proceeds of $533,000. The offering is ongoing.
	During March 2015, the compensation committee approved, under the 2012 Employee Director Stock Plan, a stock grant award to David Matthews of 500,000 shares of common stock, valued at $240,000, along with 500,000 options, at an exercise price of $0.48 and a ninety (90) day term.
	Through April 14, 2015, the Company issued an aggregate of 150,000 shares of common stock for services valued at $66,000
	Notes Payable:
	On January 29, 2015 the Company entered into a 9-month convertible note with a principal balance of $89,000 and bearing interest at 8.00% per annum.
	On March 3, 2015 the Company entered into a 9-month convertible note with a principal balance of $54,000 and bearing interest at 8.00% per annum.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2014
Summary of Significant Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation
	The accompanying consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of the Company’s majority-owned subsidiaries over which the Company exercises control. Intercompany transactions and balances were eliminated in consolidation.
Principles of Consolidation	Principles of Consolidation
	The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries, after elimination of intercompany accounts and transactions. Investments in business entities in which the Company lacks control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. The Company’s proportionate share of net income or loss of the entity is recorded in the Consolidated Statements of Operations
Use of Estimates	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates presented and reported amounts of revenues and expenses during the reporting periods presented. Significant estimates inherent in the preparation of the accompanying Consolidated Financial Statements include estimates of impairment assessment of identifiable intangible assets and valuation allowance for deferred tax assets. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents
	All highly liquid investments with maturities of three months or less at the date of purchase are considered to be cash equivalents.
Stock Compensation	Stock Compensation
	The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation” (formerly referred to as SFAS No. 123(R)). Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, ASC Topic 505, “Equity Payments to Non-Employees” or other applicable authoritative guidance.
Accounting and Reporting of Discontinued Operations	Accounting and Reporting of Discontinued Operations
	As required by the FASB ASC Subtopic 205.20, per ASU 2014-08, Discontinued Operations, a  component of an entity or a group of components of an entity, or a business or nonprofit activity can be classified as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when any of the following occurs: (i) the criteria in paragraph 205.20.45.1E to be classified as held for sale is met (ii) the component is disposed of by sale, or (iii) the component is disposed of other than by sale in accordance with paragraph 360.10.45.15 (for example, by abandonment or in a distribution to owners in a spinoff). Certain components to be disposed of other than by sale shall continue to be classified as “held and used” until it is disposed of, per the requirements of ASC Subtopic 360.10. Depreciation on these assets ceases upon their classification as “held and used.” The Company adopted ASU No. 2014-08 effective September 1, 2014.
Property and Equipment	Property and Equipment
	Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets, generally 5 to 7 years. Expenditures for additions and improvements are capitalized; repairs and maintenance are expensed as incurred.
Convertible Instruments	Convertible Instruments
	The Company evaluates and account for conversion options embedded in convertible instruments in accordance with ASC 815 “Derivatives and Hedging Activities”.
	Applicable GAAP requires companies to bifurcate conversion options from their host instruments and account for them as free standing derivative financial instruments according to certain criteria. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under other GAAP with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument.
	The Company accounts for convertible instruments (when we have determined that the embedded conversion options should not be bifurcated from their host instruments) as follows: The Company records when necessary, discounts to convertible notes for the intrinsic value of conversion options embedded in debt instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the note transaction and the effective conversion price embedded in the note. Debt discounts under these arrangements are amortized over the term of the related debt to their stated date of redemption.
Common Stock Purchase Warrants and Other Derivative Financial Instruments	Common Stock Purchase Warrants and Other Derivative Financial Instruments
	The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
Non-controlling interest in consolidated subsidiaries	Non-controlling interest in consolidated subsidiaries
	The accompanying consolidated financial statements include the accounts of Alliance BioEnergy Plus, Inc. and those subsidiaries that the Company has the ability to control either through voting rights or means other than voting rights. For these subsidiaries, the Company records 100% of the revenues, expenses, cash flows, assets and liabilities in its consolidated financial statements. For subsidiaries that the Company controls but hold less than 100% ownership, a non-controlling interest is recorded in the consolidated income statement to reflect the non-controlling interest’s share of the net income (loss), and a non-controlling interest is recorded in the consolidated balance sheet to reflect the non-controlling interest’s share of the net assets of the subsidiary.
Investments in non-consolidated subsidiaries	Investments in non-consolidated affiliates
	Investments in non-consolidated affiliates are accounted for using the equity method or cost basis depending upon the level of ownership and/or the Company's ability to exercise significant influence over the operating and financial policies of the investee. When the equity method is used, investments are recorded at original cost and adjusted periodically to recognize the Company's proportionate share of the investees' net income or losses after the date of investment. When net losses from an investment are accounted for under the equity method exceed its carrying amount, the investment balance is reduced to zero and additional losses are not provided for. The Company resumes accounting for the investment under the equity method if the entity subsequently reports net income and the Company's share of that net income exceeds the share of net losses not recognized during the period the equity method was suspended. Investments are written down only when there is clear evidence that a decline in value that is other than temporary has occurred.
	The Company’s investment in Carbolosic, LLC is accounted for using the equity method of accounting. The Company monitors its investment for impairment at least annually and make appropriate reductions in the carrying value if it determines that an impairment charge is required based on qualitative and quantitative information.
Impairment of Long Lived Assets	Impairment of Long Lived Assets
	Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable, the Company compares the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell.
Income Taxes	Income Taxes
	The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized.
	ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions for any of the reporting periods presented.
Profit (Loss) per Common Share:	Profit (Loss) per Common Share:
	Basic profit (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. The warrants and options are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive.
Fair Value Measurements	Fair Value Measurements
	The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements.
	The estimated fair value of certain financial instruments, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments.
	ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value:
	Level 1 — quoted prices in active markets for identical assets or liabilities
	Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable
	Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.
	In June 2014, the FASB issued ASU No. 2014-10, Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements, Including an Amendment to Variable Interest Entities Guidance in Topic 810, Consolidation.  The amendments in this Update remove the definition of a development stage entity from the Master Glossary of the Accounting Standards Codification, thereby removing the financial reporting distinction between development stage entities and other reporting entities from GAAP.  In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of income, cash flows, and shareholder equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer in a development stage that in prior years it had been in the development stage. The Company has elected early adoption of ASU No. 2014-10 and does not present inception to date information and other disclosure requirements of Topic 915.
	The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations.  Finally, the amendments remove paragraph 810-10-15-16. Paragraph 810-10-15-16 states that a development stage entity does not meet the condition in paragraph 810-10-15-14(a) to be a variable interest entity if (1) the entity can demonstrate that the equity invested in the legal entity is sufficient to permit it to finance the activities that it is currently engaged in and (2) the entity’s governing documents and contractual arrangements allow additional equity investments.  The amendments in this Update also eliminate an exception provided to development stage entities in Topic 810, Consolidation, for determining whether an entity is a variable interest entity on the basis of the amount of investment equity that is at risk. The amendments to eliminate that exception simplify GAAP by reducing avoidable complexity in existing accounting literature and improve the relevance of information provided to financial statement users by requiring the application of the same consolidation guidance by all reporting entities. The elimination of the exception may change the consolidation analysis, consolidation decision, and disclosure requirements for a reporting entity that has an interest in an entity in the development stage.  The amendments related to the elimination of inception-to-date information and the other remaining disclosure requirements of Topic 915 should be applied retrospectively except for the clarification to Topic 275, which shall be applied prospectively.  For public business entities, those amendments are effective for annual reporting periods beginning after December 15, 2014, and interim periods therein.  Early application of each of the amendments is permitted for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued (public business entities) or made available for issuance (other entities). The company has elected early adoption of Topic 275 for the year ended December 2014.

Investment_in_Unconsolidated_A1

Investment in Unconsolidated Affiliate (Tables)	12 Months Ended
	Dec. 31, 2014
Investment in Unconsolidated Affiliate [Abstract]
Schedule of condensed balance sheet of non-consolidated affiliate
	Condensed Balance Sheet of Non-Consolidated Affiliate
		31-Dec-14	31-Dec-13
	ASSETS
	Current Assets
	Cash and cash equivalents	$                        1,000	$                              -
	TOTAL ASSETS	$                        1,000	$                              -
	LIABILITIES AND STOCKHOLDERS EQUITY
	Current Liabilities
	Accounts payable and accrued liabilities	$                      35,000	$                              -
	Interest payable	1,218	-
	Current notes payable	381,008	-
	TOTAL CUURENT LIABILITIES	417,226	-
	STOCKHOLDERS EQUITY
	Accumulated deficit	-416,226	-
	TOTAL EQUITY	-416,226	-
	TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	$                        1,000	$                              -
Schedule of condensed statement of operations of non-consolidated affiliate
		For The Year Ended	For The Year Ended
		31-Dec-14	31-Dec-13
	Revenues	$                                 -	$                                -
	Operating Expenses
	Royalties	35,000	-
	Legal fees	377,330	-
	General and administrative	2,678	-
	Total operating expenses	-415,008	-
	Other expenses
	Interest expense	1,218	-
	Total other expenses	-1,218	-
	Loss from operations	$                   (416,226)	$                                -

Segment_Information_Tables

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2014
Segment Information [Abstract]
Summary of segment information
		December 31,
		2014		2013
	Revenue:
	Alliance BioEnergy Plus, Inc.	$	-	$	-
	Carbolosic Plant 1, LLC		-		-
	AMG Energy Group, LLC		-		-
	Central Florida Institute of Science and Technology, Inc.		-		-
	Total Revenue		-		-
	Net Operating Losses
	Alliance BioEnergy Plus, Inc.	$	7,725,009		2,215,439
	Carbolosic Plant 1, LLC		27,281		-
	AMG Energy Group, LLC		144,152		221
	Central Florida Institute of Science and Technology, Inc.		45		-
	Total Net Losses		7,896,487		2,215,660
	Total Assets:
	Alliance BioEnergy Plus, Inc.	$	447,634		1,593,364
	Carbolosic Plant 1, LLC		279,044		-
	AMG Energy Group, LLC		7,509,002		7,460,926
	Central Florida Institute of Science and Technology, Inc.		86,003		-
	Total Net Assets		8,321,683		9,054,292

Income_Taxes_Tables

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2014
Income Taxes [Abstract]
Schedule of reconciliation between statutory tax rate and effective tax rate
		Years Ended
		31-Dec-14		31-Dec-13
	Statutory federal income tax rate	-34%		-34%
	State income tax, net of federal benefits	-6%		-6%
	Valuation Allowance	40%		40%
	Income tax provision (benefit)	0%		0%
Schedule of income tax provision
		Years Ended
		31-Dec-14			31-Dec-13
	Federal
	Current	$	-		$	-
	Deferred		(3,331,666	)		(783,462	)
	State
	Current		-			-
	Deferred		(587,941	)		(138,258	)
	Change in valuation allowance		3,919,607			921,720
	Income tax provision (benefit)	$	-		$	-
Schedule of tax effects of principal temporary differences that give rise to deferred tax assets
		Years Ended
		31-Dec-14			31-Dec-13
	Deferred tax asset
	Net operating loss carryovers	$	4,883,331		$	963,724
	Total deferred tax assets		4,883,331			963,724
	Valuation Allowance		(4,883,331	)		(963,724	)
	Deferred tax asset, net of allowance	$	-		$	-

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2014
Commitments and Contingencies [Abstract]
Schedule of future minimum lease payments	YEAR ENDED	MINIMUM DUE
	2015	$	128,744
	2016		122,961
	2017		128,030
	2018		53,654
	2019		-
	TOTAL	$	433,389

Discontinued_Operations_Tables

Discontinued Operations (Tables)	12 Months Ended
	Dec. 31, 2014
Discontinued Operations [Abstract]
Schedule of disposal groups, including discontinued operations, income statement, balance sheet disclosures
		December 31,			December 31,
		2014			2013
	Carrying amounts of major classes of assets included as part of discontinued
	operations
	Cash and cash equivalents	$	-		$	11,441
	Prepaid expenses		11,263			5,300
	Property and equipment, at cost, net of accumulated depreciation at December 31,		-			42,110
	2014 and December 31, 2013, respectively
	Security deposits		-			15,000
	Investment in film and television productions		-			924,040
	Total assets of the discontinued operation	$	11,263		$	997,891
	Carrying amounts of major classes of liabilities included as part of discontinued
	operations
	Accounts payable and accrued liabilities	$	733,762		$	715,000
	Short term note payable – Related party		-			40,800
	Interest payable – Related party		-			995
	Total liabilities of the discontinued operation	$	733,762		$	756,795
		December 31,
		2014				2013
	Major line items constituting pretax profit (loss) of discontinued operations
	Revenue	$	36,540			$	-
	Cost of Sales		(23,189	)			-
	Selling, general and administrative		(991,103	)			(87,636	)
	Interest expense		(738	)			(995	)
	Loss on impairment		(924,040	)			-
	Loss from discontinued operations	$	(1,902,530	)		$	(88,639	)

Organization_Details

Organization (Details) (USD $)	1 Months Ended	12 Months Ended	1 Months Ended
	Dec. 26, 2013	Dec. 31, 2014	Jun. 18, 2014
Subsidiary, Sale of Stock [Line Items]
Controlling interest	51.00%	51.00%
Cash consideration for acquisition	$2,200,000
Amg Energy Group [Member]
Subsidiary, Sale of Stock [Line Items]
Cash consideration for acquisition		168,742
Common stock issued for acquisition	7,000,000
Loans and consulting fees	($214,894)
Carbolosic Llc [Member]
Subsidiary, Sale of Stock [Line Items]
Controlling interest	50.00%	50.00%
Wellington Asset Holdings Inc [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock issued for acquisition			266,000
Private offering [Member]
Subsidiary, Sale of Stock [Line Items]
Share consideration for acquisition	7,266,000

Going_Concern_Details

Going Concern (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Going Concern (Textuals)
Working capital deficiency	$2,337,374
Accumulated losses	($12,208,326)	($2,409,309)

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 26, 2013
Summary of Significant Accounting Policies (Textual)
Noncontrolling Interest, Ownership Percentage by Parent	51.00%	51.00%
Maximum [Member]
Summary of Significant Accounting Policies (Textual)
Property and Equipment useful lives of the assets	7 years
Minimum [Member]
Summary of Significant Accounting Policies (Textual)
Property and Equipment useful lives of the assets	5 years

Investment_in_Unconsolidated_A2

Investment in Unconsolidated Affiliate (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Current Assets
Cash and cash equivalents	$205,969	$48,968	$4
TOTAL ASSETS	8,332,946	10,052,183
Current Liabilities
Accounts payable and accrued liabilities	182,295	42,969
Interest payable	5,486	1,937
TOTAL CURRENT LIABILITIES	3,025,218	3,508,850
STOCKHOLDERS EQUITY
Accumulated deficit	-12,208,326	-2,409,309
TOTAL EQUITY	4,057,728	6,543,333	-55,165
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	8,332,946	10,052,183
Carbolosic, LLC [Member]
Current Assets
Cash and cash equivalents	1,000
TOTAL ASSETS	1,000
Current Liabilities
Accounts payable and accrued liabilities	35,000
Interest payable	1,218
Current notes payable	381,008
TOTAL CURRENT LIABILITIES	417,226
STOCKHOLDERS EQUITY
Accumulated deficit	-416,226
TOTAL EQUITY	-416,226
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	$1,000

Investment_in_Unconsolidated_A3

Investment in Unconsolidated Affiliate (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Subsidiary, Sale of Stock [Line Items]
Revenues
Operating Expenses
General and administrative	7,677,229	2,204,629
Total operating expenses	7,677,229	2,204,629
Other expenses
Total other expenses	-219,258	-11,031
Loss from operations	-9,937,560	-2,304,513
Carbolosic, LLC [Member]
Subsidiary, Sale of Stock [Line Items]
Revenues
Operating Expenses
Royalties	35,000
Legal fees	377,330
General and administrative	2,678
Total operating expenses	-415,008
Other expenses
Interest Expense	1,218
Total other expenses	-1,218
Loss from operations	($416,226)

Investment_in_Unconsolidated_A4

Investment in Unconsolidated Affiliate (Details Textual)	Dec. 31, 2014	Dec. 26, 2013
Investment in AMG Energy Group, LLC (Textual)
Controlling interest	51.00%	51.00%
Carbolosic Llc [Member]
Investment in AMG Energy Group, LLC (Textual)
Controlling interest	50.00%	50.00%

Debt_Details

Debt (Details) (USD $)	0 Months Ended	12 Months Ended	0 Months Ended		1 Months Ended
	Dec. 09, 2014	Dec. 31, 2014	Apr. 07, 2014	Jul. 06, 2012	Jan. 31, 2014	Sep. 30, 2013	Jul. 31, 2012
Debt (Textual)
Principal loan amount		$1,250,000
Long Term Notes Payable Other [Member]
Debt (Textual)
Principal balance of debt	500,000	1,250,000
Interest rate on notes payable		4.31%
Term of debt		5 years
Discount rate	0.51%	0.51%
Description of Long term Debt		The initial term on each of these loans is five (5) years from the date of each advance and bear interest at a rate of 4.31% per annum. The Company can earn a 0.51% rate discount if the first five years of interest due to lender is paid within 15 days of each advance. In addition, these loans may not be prepaid and are secured by all assets of the Company. As of December 31, 2014, the Company had received two (2) long term notes payable, with a combined principal balance of $1,250,000.
Principal loan amount		33,000,000
Interest paid	95,000
Carrying amount of debt		1,250,000
Notes Payable - Other [Member]
Debt (Textual)
Interest rate on notes payable		4.00%
Short term notes payable - other		500,000
Repayment of short term notes payable - other		500,000
Term of debt		1 year
Related Party [Member] | Convertible Debt [Member]
Debt (Textual)
Principal balance of debt				50,000			30,000
Interest rate on notes payable				10.00%			10.00%
Conversion rate				$0.12			$0.12
Conversion description				The Convertible Debentures would automatically convert into Company Common Stock at the conversion rate in the event shares of Company Common Stock traded at a price of $1.00 or more for thirty (30) consecutive trading days; in the event of a Qualified Sale (as defined in the Convertible Debenture); in the event of a merger where shareholders prior to the merger hold less than 50% of the voting power with respect to Company Common Stock following the merger; or upon the completion by the Company of an underwritten initial public offering of the Company's Common Stock with gross proceeds of at least $5,000,000.
Minimum proceeds from initial public offering				5,000,000
Face amount of convertible debt					50,000	10,000
Repayment of convertible debt principal			20,000
Debt converted into shares					458,333	83,333
Maturity date, description				Due and payable on or before July 1, 2013			Due and payable on or before July 31, 2013
Carrying amount of debt					0
Related Party [Member] | Notes Payable [Member]
Debt (Textual)
Short term notes payable description		Three of these notes were repaid and two notes were extended and remain outstanding.
Principal balance of debt		71,000
Accrued interest		$5,486
Number of Unsecured short term notes payable		5
Interest rate on notes payable		5.00%

Stockholders_Equity_Details

Stockholders' Equity (Details) (USD $)	1 Months Ended	12 Months Ended
	Nov. 30, 2013	Dec. 31, 2014		Dec. 31, 2013
Stockholders' Equity (Textual)
Number of shares authorized		110,000,000		110,000,000
Common stock, shares authorized		100,000,000		100,000,000
Common stock, par value		$0.00		$0.00
Preferred stock, shares authorized		10,000,000		10,000,000
Preferred stock, par value		$0.00		$0.00
Common stock, shares issued		40,340,738		32,840,476
Common stock, shares outstanding		40,340,738		32,840,476
Preferred stock, shares issued		0		0
Preferred Stock, Shares Outstanding		0		0
Maximum number of shares offered	12,000,000
Offering price	$0.75
Shares issued in private offering, shares		3,203,295		194,666
Shares issued in private offering, value		$2,402,180		$156,001
Shares issued for services, value		6,027,587		860,198
Stock subscription receivable		10,000
Common stock purchase to warrant		500,000		2,000,000
Term of warrant		5 years		5 years
Warrants exercise price		$1		$1
Issuance of warrants for services		278,850		902,772
Common stock, voting rights		One vote for each share held.		One vote for each share held.
Stock issued during period, value, conversion of convertible securities		57,862
Cancellation of shares		1,000,000
Stock issued during period, value, acquisitions				224,040	[1]
Issuance of common stock for prepaid expenses, value				1,500,000
Net proceeds from issuance of common stock		2,402,180		155,001
Cancellation of common stock from acquisition, value		-14,024	[1]
Stock refunded during period, value		750,000
Subsidiary company percentage		50.00%
Offering, Termination date		31-Mar-15
Consulting Agreement [Member]
Stockholders' Equity (Textual)
Common stock payable recorded as prepaid expense, value		1,500,000
Cancellation of shares		2,000,000
Services [Member]
Stockholders' Equity (Textual)
Issuance of common stock for services, Shares				4,300,477
Shares issued for services, value				2,361,198
Common Stock [Member]
Stockholders' Equity (Textual)
Issuance of common stock for services, Shares		5,689,503		2,300,477
Shares issued for services, value		5,690		2,301
Conversion of convertible debenture to common stock, shares		458,333		83,333
Stock issued during period, shares, acquisitions				1,867,000	[1]
Stock issued during period, value, acquisitions				1,867	[1]
Issuance of common stock for prepaid expenses, value				2,000
Cancellation of common stock from acquisition, Shares		-116,869	[1]
Cancellation of common stock from acquisition, value		-117	[1]
Consultant [Member]
Stockholders' Equity (Textual)
Issuance of common stock for services, Shares		3,000,000
Shares issued for services, value		$3,450,000
Constellation Asset Advisors Inc [Member]
Stockholders' Equity (Textual)
Issuance of common stock for services, Shares		967,810
[1]	(1) Stock issued for rights to two partially-completed television series "World Star" and "Making of a Saint: The Journey to Sainthood"

Segment_Information_Details

Segment Information (Details) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Total Revenue
Total Net Losses	-9,799,017	-2,304,299
Total Net Assets	8,332,946	10,052,183
Alliance BioEnergy Plus, Inc. [Member]
Segment Reporting Information [Line Items]
Total Revenue
Total Net Losses	7,725,009	2,215,439
Total Net Assets	447,634	1,593,364
Carbolosic Plant 1, LLC [Member]
Segment Reporting Information [Line Items]
Total Revenue
Total Net Losses	27,281
Total Net Assets	279,044
AMG Energy Group, LLC [Member]
Segment Reporting Information [Line Items]
Total Revenue
Total Net Losses	144,152	221
Total Net Assets	7,509,002	7,460,926
Central Florida Institute of Science and Technology, Inc. [Member]
Segment Reporting Information [Line Items]
Total Revenue
Total Net Losses	45
Total Net Assets	$86,003

Income_Taxes_Details

Income Taxes (Details)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Abstract]
Statutory federal income tax rate	-34.00%	-34.00%
State income tax, net of federal benefits	-6.00%	-6.00%
Valuation Allowance	40.00%	40.00%
Income tax provision (benefit)	0.00%	0.00%

Income_Taxes_Details_1

Income Taxes (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Federal
Current
Deferred	-3,331,666	-783,462
State
Current
Deferred	-587,941	-138,258
Change in valuation allowance	3,919,607	921,720
Income tax provision (benefit)

Income_Taxes_Details_2

Income Taxes (Details 2) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Deferred tax asset
Net operating loss carryovers	$4,883,331	$963,724
Total deferred tax assets	4,883,331	963,724
Valuation Allowance	-4,883,331	-963,724
Deferred tax asset, net of allowance

Income_Taxes_Details_Textual

Income Taxes (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Income Taxes (Textual)
Federal net operating loss carryovers	$12,208,326	$2,409,309
Reconciliation of income tax benefit U.S.statutory rate	-34.00%	-34.00%
Operating loss carryovers, Expiration date	31-Dec-33
Operating loss carryovers, Limitations on use	The NOLs may be subject to limitation under the Internal Revenue Code Section 382 should there be a greater than 50% ownership change as determined under regulations.

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Dec. 31, 2014
Commitments and Contingencies [Abstract]
2015	$128,744
2016	122,961
2017	128,030
2018	53,654
2019
TOTAL	$433,389

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Textual) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Commitments and Contingencies (Textual)
Rent expense	$90,396	$32,639
Office Lease [Member]
Commitments and Contingencies (Textual)
Lease termination date	5-Aug-15
Annual rent	46,250
Term of lease	40 months
Percentage of increase in rent per year	3.00%
Commitments description	The Company is obligated to pay an amount equal to 3.76% of the operating expenses of the building together with sales tax on all amounts.
Office Lease I [Member]
Commitments and Contingencies (Textual)
Lease termination date	31-Oct-18
Annual rent	$51,338
Term of lease	54 months
Percentage of increase in rent per year	3.00%
Commitments description	The rent commencement date is November 1, 2014. Annual rent commences at approximately $51,338 per annum and increases on a year-to-year basis by 3% over the Base Year.

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	12 Months Ended		0 Months Ended	1 Months Ended	0 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 15, 2014	Oct. 31, 2014	Jun. 05, 2014	Jun. 11, 2014	Dec. 26, 2013
	Consultant
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Holding company percentage	51.00%						51.00%
Monthly payment per consultant	$10,000
Affiliate company percentage	50.00%
Number of consulting agreements	3
Common stock purchase to warrant	500,000	2,000,000
Shares issued for services, value	6,027,587	860,198
Stock refunded during period, value	750,000
Cancellation of shares	1,000,000
Warrant Purchase Agreements [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Affiliate company percentage			50.00%
Common stock issued				1,000,000
Common stock purchase to warrant				1,000,000
Stock refunded during period, value			750,000
Cancellation of warrant agreement	1,000,000
Blake Koch [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Marketing and advertising expense					25,000
Joseph McNaney [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Issuance of common stock for services, Shares						3,000,000
Shares issued for services, value						$3,450,000
Mark W Koch [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Affiliate company percentage	43.00%
Daniel De Liege [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Affiliate company percentage	43.00%

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	Dec. 31, 2014	Dec. 31, 2013
Carrying amounts of major classes of assets included as part of discontinued operations
Cash and cash equivalents		$11,441
Prepaid expenses	11,263	5,300
Property and equipment, at cost, net of accumulated depreciation at December 31, 2014 and December 31, 2013, respectively		42,110
Security deposits		15,000
Investment in film and television productions		924,040
Total assets of the discontinued operation	11,263	997,891
Carrying amounts of major classes of liabilities included as part of discontinued operations
Accounts payable and accrued liabilities	733,762	715,000
Short term note payable - Related party		40,800
Interest payable - Related party		995
Total liabilities of the discontinued operation	$733,762	$756,795

Discontinued_Operations_Detail1

Discontinued Operations (Details 1) (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Major line items constituting pretax profit (loss) of discontinued operations
Revenue	$36,540
Cost of Sales	-23,189
Selling, general and administrative	-991,103	-87,636
Interest expense	-738	-995
Loss on impairment	-924,040
Loss from discontinued operations	($1,902,530)	($88,639)

Subsequent_Events_Details

Subsequent Events (Details) (USD $)	12 Months Ended		0 Months Ended			1 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Apr. 14, 2015	Mar. 03, 2015	Jan. 29, 2015	Mar. 31, 2015	Feb. 28, 2015	Nov. 30, 2013
Subsequent Event (Textual)
Offering price								$0.75
Warrants exercise price	$1	$1
Issuance of common stock	3,203,295	194,666
Issuance of common stock, Value	$2,402,180	$156,001
Issuance of common stock for services, value	6,027,587	860,198
Subsequent Event [Member]
Subsequent Event (Textual)
Issued shares cancelled							460,215
Company's shares for services cancelled							500,000
Cancellation of shares							1,000,000
Forfeiture of rights on unissued shares							3,000,000
Shares issued in offering			1,687,702
shares available for sale in initial offering							12,000,000
Offering price							$0.75
Description of shares issued in 2nd offering							The Company opened a 2nd offering of units valued at eight-five (85%) percent of the average of the last three days closing market share price. Each unit consists of one (1) share of Common Stock, one (1) three-year Series A Warrant convertible to .5 Common Share at an exercise price of $0.75 and one (1) three-year series B Warrant convertible to .5 Common Share at an exercise price of $1.50.
Proceeds from issuance of stock			533,000
Issuance of common stock						500,000
Issuance of common stock, Value						240,000
Options granted						500,000
Exercise price						$0.48
Term of options						90 days
Issuance of common stock for services, Shares			150,000
Issuance of common stock for services, value			66,000
Convertible notes payable				$54,000	$89,000
Interest rate				8.00%	8.00%
Convertible notes payable, Term				9 months	9 months
Subsequent Event [Member] | Series A Warrant [Member]
Subsequent Event (Textual)
Conversion of warrants to common stock							0.5
Term of warrants							3 years
Warrants exercise price							$0.75
Subsequent Event [Member] | Series B Warrant [Member]
Subsequent Event (Textual)
Conversion of warrants to common stock							0.5
Term of warrants							3 years
Warrants exercise price							$1.50